Advanced Nanomaterials in Biomedical Application
This Special Issue on "Advanced Nanomaterials in Biomedical Application" aimed to showcase the most recent advances in nanomaterials, not only in terms of their synthesis and characterization, but also their technological application. This Special Issue welcomed the submission of original...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_113986 | ||
| 005 | 20230911 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230911s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-8612-0 | ||
| 020 | |a 9783036586137 | ||
| 020 | |a 9783036586120 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-8612-0 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 100 | 1 | |a Kaluđerović, Goran |4 edt | |
| 700 | 1 | |a Pantelić, Nebojša |4 edt | |
| 700 | 1 | |a Kaluđerović, Goran |4 oth | |
| 700 | 1 | |a Pantelić, Nebojša |4 oth | |
| 245 | 1 | 0 | |a Advanced Nanomaterials in Biomedical Application |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (360 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This Special Issue on "Advanced Nanomaterials in Biomedical Application" aimed to showcase the most recent advances in nanomaterials, not only in terms of their synthesis and characterization, but also their technological application. This Special Issue welcomed the submission of original research articles and reviews. Research areas include all types of nanomaterials used in the development of medical applications (e.g., therapeutic: anticancer, antibacterial, toxicology; diagnostic: imaging; nanodevices, and others). | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 653 | |a colorimetric discrimination | ||
| 653 | |a giant polyoxometalate | ||
| 653 | |a HPV capsid protein | ||
| 653 | |a hypochromic of molybdate clusters | ||
| 653 | |a opposite color response | ||
| 653 | |a nanoparticles | ||
| 653 | |a cell tracking | ||
| 653 | |a cell labelling | ||
| 653 | |a cell uptake | ||
| 653 | |a stem cell homing | ||
| 653 | |a coronaviruses | ||
| 653 | |a vaccines | ||
| 653 | |a diagnostic nanoparticles | ||
| 653 | |a magnetic nanoparticles | ||
| 653 | |a fluorination | ||
| 653 | |a polyethyleneimine | ||
| 653 | |a polyethylene glycol | ||
| 653 | |a RNA interference | ||
| 653 | |a CXC chemokine receptor 4 | ||
| 653 | |a dual-crosslinked hydrogel | ||
| 653 | |a glycol chitosan | ||
| 653 | |a bioactive glass nanoparticles | ||
| 653 | |a amino functionalization | ||
| 653 | |a strength and elasticity | ||
| 653 | |a PLGA nanoparticles | ||
| 653 | |a anti-inflammatory | ||
| 653 | |a controlled drug delivery | ||
| 653 | |a nanomaterials | ||
| 653 | |a platinum-based drug | ||
| 653 | |a graphene oxide | ||
| 653 | |a breast cancer | ||
| 653 | |a osteosarcoma | ||
| 653 | |a glioblastoma | ||
| 653 | |a nanomedicine | ||
| 653 | |a drug delivery systems | ||
| 653 | |a Candida albicans | ||
| 653 | |a β-glucan | ||
| 653 | |a infection | ||
| 653 | |a inflammation | ||
| 653 | |a glass ionomer cements | ||
| 653 | |a chlorhexidine | ||
| 653 | |a nanotubes | ||
| 653 | |a microhardness | ||
| 653 | |a compressive strength | ||
| 653 | |a silver nanoparticles | ||
| 653 | |a nanosilica | ||
| 653 | |a graphene oxide composites | ||
| 653 | |a antibacterial effect | ||
| 653 | |a Escherichia coli | ||
| 653 | |a bacillus subtilis | ||
| 653 | |a platinum(IV) conjugates | ||
| 653 | |a cisplatin | ||
| 653 | |a phenolic acid | ||
| 653 | |a drug delivery | ||
| 653 | |a multidrug-resistant bacteria | ||
| 653 | |a antimicrobial | ||
| 653 | |a nano-emulsion | ||
| 653 | |a adjuvants | ||
| 653 | |a FMD virus-like particles | ||
| 653 | |a squalane | ||
| 653 | |a immune responses | ||
| 653 | |a poly-3-hydroxybutyrate | ||
| 653 | |a hemin | ||
| 653 | |a electrospun fibrous materials | ||
| 653 | |a biocompatibility | ||
| 653 | |a antimicrobial activity | ||
| 653 | |a liposome | ||
| 653 | |a oral drug delivery systems | ||
| 653 | |a osmoregulatory peptide | ||
| 653 | |a mucus layers | ||
| 653 | |a intestinal epithelial permeability | ||
| 653 | |a bone regeneration | ||
| 653 | |a osteoimmunomodulation | ||
| 653 | |a targeted drug delivery | ||
| 653 | |a targeting nanoparticles | ||
| 653 | |a linkers | ||
| 653 | |a passive targeting | ||
| 653 | |a active targeting | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7830 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/113986 |7 0 |z DOAB: description of the publication |